Hiroshi Ishii

7.4k citations
180 papers · 4.4k indexed · h-index 37

Hiroshi Ishii

167 papers receiving 4.3k citations

Peers

Hiroshi Ishii
Comparison fields: 5 of 126
  • Hepatology 1.3k
  • Oncology 2.3k
  • Cancer Research 716
  • Pulmonary and Respiratory Medicine 1.2k
  • Surgery 1.3k
Replace Chigusa Morizane with:
Chigusa Morizane Japan
Yehuda Z. Patt United States
Fritz Wrba Austria
Benjamin Tan United States
Takashi Maeda Japan
Mary A. Maluccio United States
Haeryoung Kim South Korea
Tan To Cheung Hong Kong
Philippe Rougier France
Uta Drebber Germany
Hiroshi Ishii relative to Chigusa Morizane Japan Chigusa Morizane's profile →
Citations per field
00.5×1.5×2.2×
Chigusa Morizane · 1×
Citations per year

Countries citing papers authored by Hiroshi Ishii

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ishii more than expected).

Fields of papers citing papers by Hiroshi Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ishii. The network helps show where Hiroshi Ishii may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroshi Ishii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroshi Ishii Line = papers co-authored together Hiroshi Ishii links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20238
3 2019124
4 20183
5 20178
6 20172
7 2016110
8 20143
9 20142
10 201380
11 2012251
12 20114
13 20061
14 200642
15 20051
16 200427
17 19992
18
Surgical Treatment of Primary Lung Cancer Complicated by Pleural Empyema : A Case Report
19971
19 19911
20 19908

About Hiroshi Ishii

Hiroshi Ishii is a scholar working on Hepatology, Oncology and Microbiology, having authored 180 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (71 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (44 papers), Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Cancer Genomics and Diagnostics (29 papers), Neuroendocrine Tumor Research Advances (20 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Mechanisms and Therapy (14 papers) and Gallbladder and Bile Duct Disorders (14 papers). The work is most often cited by research in Hepatology (1.3k citations), Oncology (2.3k citations) and Cancer Research (716 citations). Hiroshi Ishii has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Junji Furuse, Takuji Okusaka, Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Kohei Nakachi, Michitaka Nagase, Masahiro Yoshino, Masayoshi Yoshimori and Masaru Konishi. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026